Acelabio
AcelaBio is seeking a senior finance professional to lead its finance and accounting function end‑to‑end, overseeing daily accounting operations, financial reporting, budgeting, forecasting, systems, internal controls, and compliance. The role will partner with executive leadership and the Board to provide accurate financial information, support strategic decision‑making, and build the infrastructure needed for the company’s independent growth.
Headquarters
San Diego, California, United States
Company Size
11-50 employees
Founded
2020
AcelaBio is a specialized CRO that provides histopathology and precision medicine services to support global clinical trials. They deliver tissue-based biomarker assays and pathology services including slide processing, staining (e.g., IHC), expert pathology review, digital slide scanning, and image analysis to enable biomarker development and companion-diagnostic workflows. AcelaBio works with pharmaceutical and biotech sponsors, offering regulated, quality-driven lab operations, integrated logistics, and anatomic pathology expertise to produce reproducible tissue data for clinical and regulatory programs. The company positions itself as a scalable partner for precision-medicine and tissue-based endpoints across multicenter trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Acelabio.
44% above the average for this role